Your browser doesn't support javascript.
loading
Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
Busse, William W; Brusselle, Guy G; Korn, Stephanie; Kuna, Piotr; Magnan, Antoine; Cohen, David; Bowen, Karin; Piechowiak, Teresa; Wang, Millie M; Colice, Gene.
Afiliação
  • Busse WW; Dept of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
  • Brusselle GG; Dept of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.
  • Korn S; Pulmonary Dept, Mainz University Hospital, Mainz, Germany.
  • Kuna P; Dept of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
  • Magnan A; Institut du Thorax, INSERM CNRS, Université de Nantes, CHU de Nantes, Nantes, France.
  • Cohen D; AstraZeneca, Gaithersburg, MD, USA.
  • Bowen K; AstraZeneca, Gaithersburg, MD, USA.
  • Piechowiak T; AstraZeneca, Mississauga, ON, Canada.
  • Wang MM; AstraZeneca, Cambridge, UK.
  • Colice G; AstraZeneca, Gaithersburg, MD, USA.
Eur Respir J ; 53(2)2019 02.
Article em En | MEDLINE | ID: mdl-30442714
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Corticosteroides / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Asma / Corticosteroides / Anticorpos Monoclonais Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article